Serum concentrations of oestrone, oestradiol and oestriol during various oestrogen treatments.
Serum oestradiol/oestrone ratios were measured during various oestrogen treatments in castrated women. Oral oestriol succinate therapy (8 mg/day) caused little change in the pre-treatment oestradiol/oestrone ratio. During oestradiol valerianate therapy (2 mg/day) serum total oestrogens and the E2/I1 ratio were considerably increased. One day after the injection of 10 mg of oestradiol valerianate and 2.5 mg of oestradiol benzoate + 10 mg of oestradiol phenylpropionate the E2/E1 ratio was similar to the ratio in middle of the normal ovulatory cycle. The change in serum oestriol was rather small after oral doses of 8 mg og oestriol succinate 15, 30 and 120 min after the application.
D004958:Estradiol / Q000031:analogs & derivatives / Q000097:blood* / Q000627:therapeutic use; D004964:Estriol / Q000031:analogs & derivatives / Q000097:blood* / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use*; D004970:Estrone / Q000097:blood*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged
D004967:Estrogens; D004970:Estrone; D004958:Estradiol; C009341:estriol succinate; D004964:Estriol; C017294:estradiol-17-phenylpropionate